Results 71 to 80 of about 258,704 (366)
Hormone Replacement Therapy, Likely Neither Angel Nor Demon. [PDF]
PLoS ONE, 2015 A decline in breast cancer incidence has been attributed to the reduction in hormone replacement therapy (HRT) prescriptions since the publication of the landmark WHIT paper in 2003.
Mitchell S Wachtel +3 more
doaj +1 more source
Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis [PDF]
, 2002 Hormone replacement therapy (HRT) increases the risk of venous thrombosis. We investigated whether this risk is affected by carriership of hereditary prothrombotic abnormalities.
A. Rumley +26 more
core +1 more source
3D Bioprinting of Thick Adipose Tissues with Integrated Vascular Hierarchies
Advanced Functional Materials, Volume 35, Issue 12, March 18, 2025.An advanced 3D bioprinting technique is used here to create thick adipose tissues with a central, vessel and extensive branching. The construct is made using alginate, gelatin and collagen‐based bioinks. Flow through the complex vessel network is demonstrated as well as its successful integration with a femoral artery following implantation in a rat ...
Idit Goldfracht +5 more
wiley +1 more source
HORMONE REPLACEMENT THERAPY AND CANCER
Zdravniški Vestnik, 2003 Background. Sex steroids are not known to damage DNA directly. They can stimulate or inhibit cell proliferation, and thus can modulate tumor developmental progression.Results.
Marjetka Uršič Vrščaj
doaj
Towards Personalized Prostate Cancer Therapy Using Delta-Reachability Analysis [PDF]
, 2014 Recent clinical studies suggest that the efficacy of hormone therapy for prostate cancer depends on the characteristics of individual patients. In this paper, we develop a computational framework for identifying patient-specific androgen ablation therapy schedules for postponing the potential cancer relapse.
arxiv +1 more source
Intraoral Drug Delivery: Bridging the Gap Between Academic Research and Industrial Innovations
Advanced Functional Materials, EarlyView.Intraoral drug delivery offers a promising route for systemic and localized therapies, yet challenges such as enzymatic degradation, limited permeability, and microbial interactions hinder efficacy. This figure highlights innovative strategies—mucoadhesive materials, enzyme inhibitors, and permeation enhancers—to overcome these barriers.
Soheil Haddadzadegan +4 more
wiley +1 more source
OSTEOPOROSIS AND HORMONE REPLACEMENT THERAPY
Zdravniški Vestnik, 2008 BACKGROUND Osteoporosis affects almost every other woman after menopause. Fractures due to osteoporosis are a significant cause of disability and death, therefore we try to prevent themwith antiosteoporotic medications.Hormone replacement therapy (HRT ...
Tomaž Kocjan, Damir Franić
doaj
Treatment of symptoms of the menopause: an endocrine society clinical practice guideline [PDF]
, 2015 Objective: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. Participants: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and
Davis, Susan R. +6 more
core +1 more source
Advanced Healthcare Materials, EarlyView.Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray +2 more
wiley +1 more source
Significance of hormone replacement therapy in the experience of Lymphedema in breast cancer survivors [PDF]
, 2008 only availableLittle is known about the relationship between hormone replacement therapy and Lymphedema (LE), the accumulation of lymph in soft tissue with accompanying swelling that affects 20-40% of breast cancer survivors, mainly in the upper ...
Armer, Jane M., Huff, Danielle
core